Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PFIZER INCPFE · Entity 2863 | Executive Vice President | March 03, 2026 | March 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PFIZER INC
Report date March 03, 2026 · Filed March 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $26.58 · Expires 2031-03-03 | Direct | 194,883 |
Reported balance
After 2026-03-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-03 · Grant · Acquired 194,883 · Balance 194,883 F1: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 26, 2021 Filed Nov 30, 2021 21:30 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 5,856 | $54.31 | $318,039.36 |
DisclosureSEC source: 0001225208-21-014220 · doc4.xml · nonDerivative · entry 11 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,717 Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 21:30 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 5,765 | $54.40 | $313,616.00 |
DisclosureSEC source: 0001225208-21-014220 · doc4.xml · nonDerivative · entry 10 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,573 Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 21:30 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 5,203 | $54.17 | $281,846.51 |
DisclosureSEC source: 0001225208-21-014220 · doc4.xml · nonDerivative · entry 9 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,338 Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 21:30 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 4,500 | $54.55 | $245,475.00 |
DisclosureSEC source: 0001225208-21-014220 · doc4.xml · nonDerivative · entry 8 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,541 Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 21:30 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 4,200 | $54.50 | $228,900.00 |
DisclosureSEC source: 0001225208-21-014220 · doc4.xml · nonDerivative · entry 7 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,041 Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 21:30 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 2,736 | $54.39 | $148,811.04 |
DisclosureSEC source: 0001225208-21-014220 · doc4.xml · nonDerivative · entry 6 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,241 Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 21:30 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 1,677 | $54.46 | $91,329.42 |
DisclosureSEC source: 0001225208-21-014220 · doc4.xml · nonDerivative · entry 5 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,977 Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 21:30 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 1,497 | $54.47 | $81,541.59 |
DisclosureSEC source: 0001225208-21-014220 · doc4.xml · nonDerivative · entry 4 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,654 Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 21:30 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 1,133 | $54.26 | $61,476.58 |
DisclosureSEC source: 0001225208-21-014220 · doc4.xml · nonDerivative · entry 3 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,151 Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 21:30 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 909 | $54.45 | $49,495.05 |
DisclosureSEC source: 0001225208-21-014220 · doc4.xml · nonDerivative · entry 2 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,284 Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 21:30 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 124 | $54.32 | $6,735.68 |
DisclosureSEC source: 0001225208-21-014220 · doc4.xml · nonDerivative · entry 1 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,193 Read SEC document |
| February 27, 2021 Filed Mar 2, 2021 23:00 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 53,925 | $0.00 Strike: $22.35 | $0.00 |
DisclosureSEC source: 0001225208-21-004320 · doc4.xml · derivative · entry 5 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 53,925 shares Expires 2021-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2021 Filed Mar 2, 2021 23:00 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 34,191 | $34.64 | $1,184,376.24 |
DisclosureSEC source: 0001225208-21-004320 · doc4.xml · nonDerivative · entry 3 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,317 F4 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F5 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 27, 2021 Filed Mar 2, 2021 23:00 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 9,664 | $33.49 | $323,647.36 |
DisclosureSEC source: 0001225208-21-004320 · doc4.xml · nonDerivative · entry 2 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,508 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. F3 · price: Price is the closing price of Pfizer common stock on February 26, 2021. Read SEC document |
| February 27, 2021 Filed Mar 2, 2021 23:00 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 53,925 | $22.35 | $1,205,223.75 |
DisclosureSEC source: 0001225208-21-004320 · doc4.xml · nonDerivative · entry 1 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:05 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 106,195 | $0.00 Strike: $33.82 | $0.00 |
DisclosureSEC source: 0001225208-21-004052 · doc4.xml · derivative · entry 7 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,195 Underlying: Common Stock · 106,195 shares Expires 2028-02-25 F6 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F6 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:05 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 122,907 | $0.00 Strike: $33.82 | $0.00 |
DisclosureSEC source: 0001225208-21-004052 · doc4.xml · derivative · entry 6 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,907 Underlying: Common Stock · 122,907 shares Expires 2026-02-25 F5 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F5 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:05 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 99,816 | $0.00 Strike: $22.89 | $0.00 |
DisclosureSEC source: 0001225208-21-004052 · doc4.xml · derivative · entry 5 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 99,816 shares Expires 2021-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:05 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 64,599 | $34.76 | $2,245,461.24 |
DisclosureSEC source: 0001225208-21-004052 · doc4.xml · nonDerivative · entry 3 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,247 F3 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F4 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:05 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 17,246 | $33.82 | $583,259.72 |
DisclosureSEC source: 0001225208-21-004052 · doc4.xml · nonDerivative · entry 2 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,846 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:05 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 99,816 | $22.89 | $2,284,788.24 |
DisclosureSEC source: 0001225208-21-004052 · doc4.xml · nonDerivative · entry 1 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,092 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| December 16, 2020 Filed Dec 18, 2020 01:11 UTC | PFIZER INC PFE · Entity 2863 | OtherPhantom Stock Units SSP · Derivative | 5,442 | $37.84 | $205,925.28 |
DisclosureSEC source: 0001225208-20-014834 · doc4.xml · derivative · entry 1 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,737 Underlying: Common Stock · 5,442 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: This transaction constitutes an intra-plan transfer into the Pfizer stock unit fund under the Pfizer Inc. Supplemental Savings Plan. F3 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F3 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 29, 2020 Filed May 1, 2020 19:56 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 57,099 | $37.83 | $2,160,055.17 |
DisclosureSEC source: 0001225208-20-006951 · doc4.xml · nonDerivative · entry 2 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,276 Read SEC document |
| April 29, 2020 Filed May 1, 2020 19:56 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 7,901 | $38.01 | $300,317.01 |
DisclosureSEC source: 0001225208-20-006951 · doc4.xml · nonDerivative · entry 1 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,375 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 17:54 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 38,848 | $0.00 Strike: $27.37 | $0.00 |
DisclosureSEC source: 0001225208-20-004024 · doc4.xml · derivative · entry 5 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 38,848 shares Expires 2020-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 17:54 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 20,069 | $36.45 | $731,515.05 |
DisclosureSEC source: 0001225208-20-004024 · doc4.xml · nonDerivative · entry 3 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,276 F3 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F4 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 17:54 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 9,197 | $33.42 | $307,363.74 |
DisclosureSEC source: 0001225208-20-004024 · doc4.xml · nonDerivative · entry 2 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,345 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 17:54 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 38,848 | $27.37 | $1,063,269.76 |
DisclosureSEC source: 0001225208-20-004024 · doc4.xml · nonDerivative · entry 1 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,542 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 27, 2020 Filed Feb 29, 2020 00:25 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 127,722 | $0.00 Strike: $34.10 | $0.00 |
DisclosureSEC source: 0001225208-20-003801 · doc4.xml · derivative · entry 9 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,722 Underlying: Common Stock · 127,722 shares Expires 2027-02-27 F8 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F8 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 27, 2020 Filed Feb 29, 2020 00:25 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 149,072 | $0.00 Strike: $34.10 | $0.00 |
DisclosureSEC source: 0001225208-20-003801 · doc4.xml · derivative · entry 8 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,072 Underlying: Common Stock · 149,072 shares Expires 2025-02-27 F7 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F7 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 00:25 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 88,567 | $0.00 Strike: $34.59 | $0.00 |
DisclosureSEC source: 0001225208-20-003801 · doc4.xml · derivative · entry 7 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 88,567 shares Expires 2020-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 00:25 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 67,605 | $36.80 | $2,487,864.00 |
DisclosureSEC source: 0001225208-20-003801 · doc4.xml · nonDerivative · entry 5 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,694 F5 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F6 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 00:25 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 15,691 | $34.72 | $544,791.52 |
DisclosureSEC source: 0001225208-20-003801 · doc4.xml · nonDerivative · entry 4 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,299 F4 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 00:25 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 7,121 | $34.72 | $247,241.12 |
DisclosureSEC source: 0001225208-20-003801 · doc4.xml · nonDerivative · entry 3 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,990 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 00:25 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 34,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-003801 · doc4.xml · nonDerivative · entry 2 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,111 F2 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 00:25 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 88,567 | $34.59 | $3,063,532.53 |
DisclosureSEC source: 0001225208-20-003801 · doc4.xml · nonDerivative · entry 1 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,936 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| August 14, 2019 Filed Aug 15, 2019 19:17 UTC | PFIZER INC PFE · Entity 2863 | OtherPhantom Stock Units SSP · Derivative | 14,154 | $34.24 | $484,632.96 |
DisclosureSEC source: 0001225208-19-011437 · doc4.xml · derivative · entry 1 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,285 Underlying: Common Stock · 14,154 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: This transaction constitutes an intra-plan transfer into the Pfizer stock unit fund under the Pfizer Inc. Supplemental Savings Plan. F3 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F3 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| February 28, 2019 Filed Mar 2, 2019 00:37 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 76,057 | $0.00 Strike: $43.35 | $0.00 |
DisclosureSEC source: 0001225208-19-004214 · doc4.xml · derivative · entry 9 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,057 Underlying: Common Stock · 76,057 shares Expires 2026-02-28 F8 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F8 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 28, 2019 Filed Mar 2, 2019 00:37 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 90,251 | $0.00 Strike: $43.35 | $0.00 |
DisclosureSEC source: 0001225208-19-004214 · doc4.xml · derivative · entry 8 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,251 Underlying: Common Stock · 90,251 shares Expires 2024-02-28 F7 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F7 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:37 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 64,322 | $0.00 Strike: $32.23 | $0.00 |
DisclosureSEC source: 0001225208-19-004214 · doc4.xml · derivative · entry 7 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 64,322 shares Expires 2019-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:37 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 39,724 | $42.31 | $1,680,722.44 |
DisclosureSEC source: 0001225208-19-004214 · doc4.xml · nonDerivative · entry 5 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,369 F5 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F6 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:37 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 28,784 | $42.93 | $1,235,697.12 |
DisclosureSEC source: 0001225208-19-004214 · doc4.xml · nonDerivative · entry 4 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,093 F4 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:37 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 12,046 | $42.93 | $517,134.78 |
DisclosureSEC source: 0001225208-19-004214 · doc4.xml · nonDerivative · entry 3 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,877 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:37 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 58,778 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-004214 · doc4.xml · nonDerivative · entry 2 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,923 F2 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:37 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 64,322 | $32.23 | $2,073,098.06 |
DisclosureSEC source: 0001225208-19-004214 · doc4.xml · nonDerivative · entry 1 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,145 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 23, 2019 Filed Feb 27, 2019 00:45 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 43,724 | $0.00 Strike: $21.03 | $0.00 |
DisclosureSEC source: 0001225208-19-003777 · doc4.xml · derivative · entry 5 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 43,724 shares Expires 2019-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2019 Filed Feb 27, 2019 00:45 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 13,615 | $41.91 | $570,604.65 |
DisclosureSEC source: 0001225208-19-003777 · doc4.xml · nonDerivative · entry 3 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,823 F4 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F5 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 23, 2019 Filed Feb 27, 2019 00:45 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 11,343 | $42.96 | $487,295.28 |
DisclosureSEC source: 0001225208-19-003777 · doc4.xml · nonDerivative · entry 2 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,438 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. F3 · price: Price is the closing price of Pfizer common stock on February 22, 2019 Read SEC document |
| February 23, 2019 Filed Feb 27, 2019 00:45 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 43,724 | $21.03 | $919,515.72 |
DisclosureSEC source: 0001225208-19-003777 · doc4.xml · nonDerivative · entry 1 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,781 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 01, 2019 Filed Feb 2, 2019 00:21 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 5,000 | $42.75 | $213,750.00 |
DisclosureSEC source: 0001225208-19-001685 · doc4.xml · nonDerivative · entry 9 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,057 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.